http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 07 Sep 2022 02:09:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html si-local-file:///var/storage/newsbody/2022/0907/20555213.html http://www.streetinsider.com/Press+Releases/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html Wed, 07 Sep 2022 02:09:00 -0400 ALZ ALZ O.12247820 http://www.streetinsider.com/Press+Releases/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html si-local-file:///var/storage/newsbody/2022/0907/20555213.html http://www.streetinsider.com/Press+Releases/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html Wed, 07 Sep 2022 02:09:00 -0400 ALZ ALZ O.12247820 http://www.streetinsider.com/Press+Releases/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html si-local-file:///var/storage/newsbody/2022/0907/20555213.html http://www.streetinsider.com/Press+Releases/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html Wed, 07 Sep 2022 02:09:00 -0400 ALZ ALZ O.12247820 http://www.streetinsider.com/PRNewswire/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html si-local-file:///var/storage/newsbody/2022/0907/20555213.html http://www.streetinsider.com/PRNewswire/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html Wed, 07 Sep 2022 02:09:00 -0400 ALZ ALZ O.12247820 http://www.streetinsider.com/PRNewswire/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html si-local-file:///var/storage/newsbody/2022/0907/20555213.html http://www.streetinsider.com/PRNewswire/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html Wed, 07 Sep 2022 02:09:00 -0400 ALZ ALZ O.12247820 http://www.streetinsider.com/PRNewswire/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html si-local-file:///var/storage/newsbody/2022/0907/20555213.html http://www.streetinsider.com/PRNewswire/Alzinova+announces+new+positive+safety+review+of+its+Phase+1b+study+in+Alzheimer%27s+disease/20555213.html Wed, 07 Sep 2022 02:09:00 -0400 ALZ ALZ O.12247820 http://www.streetinsider.com/Press+Releases/Alzinova+initiates+development+of+a+stable+cell+line+to+prepare+the+monoclonal+antibody+ALZ-201+for+Alzheimer%27s+clinical+trials/20121666.html si-local-file:///var/storage/newsbody/2022/0524/20121666.html http://www.streetinsider.com/Press+Releases/Alzinova+initiates+development+of+a+stable+cell+line+to+prepare+the+monoclonal+antibody+ALZ-201+for+Alzheimer%27s+clinical+trials/20121666.html Tue, 24 May 2022 10:05:00 -0400 ALZ http://www.streetinsider.com/PRNewswire/Alzinova+initiates+development+of+a+stable+cell+line+to+prepare+the+monoclonal+antibody+ALZ-201+for+Alzheimer%27s+clinical+trials/20121666.html si-local-file:///var/storage/newsbody/2022/0524/20121666.html http://www.streetinsider.com/PRNewswire/Alzinova+initiates+development+of+a+stable+cell+line+to+prepare+the+monoclonal+antibody+ALZ-201+for+Alzheimer%27s+clinical+trials/20121666.html Tue, 24 May 2022 10:05:00 -0400 ALZ http://www.streetinsider.com/Press+Releases/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html si-local-file:///var/storage/newsbody/2022/0428/19973506.html http://www.streetinsider.com/Press+Releases/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html Thu, 28 Apr 2022 02:37:00 -0400 ALZ ALZ http://www.streetinsider.com/Press+Releases/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html si-local-file:///var/storage/newsbody/2022/0428/19973506.html http://www.streetinsider.com/Press+Releases/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html Thu, 28 Apr 2022 02:37:00 -0400 ALZ ALZ http://www.streetinsider.com/PRNewswire/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html si-local-file:///var/storage/newsbody/2022/0428/19973506.html http://www.streetinsider.com/PRNewswire/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html Thu, 28 Apr 2022 02:37:00 -0400 ALZ ALZ http://www.streetinsider.com/PRNewswire/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html si-local-file:///var/storage/newsbody/2022/0428/19973506.html http://www.streetinsider.com/PRNewswire/Alzinova+announces+positive+safety+review+and+continuation+of+its+Phase+1b+study+in+Alzheimer%27s+disease/19973506.html Thu, 28 Apr 2022 02:37:00 -0400 ALZ ALZ http://www.streetinsider.com/Press+Releases/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html si-local-file:///var/storage/newsbody/2022/0330/19841942.html http://www.streetinsider.com/Press+Releases/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html Wed, 30 Mar 2022 02:19:00 -0400 ALZ ALZ http://www.streetinsider.com/Press+Releases/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html si-local-file:///var/storage/newsbody/2022/0330/19841942.html http://www.streetinsider.com/Press+Releases/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html Wed, 30 Mar 2022 02:19:00 -0400 ALZ ALZ http://www.streetinsider.com/PRNewswire/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html si-local-file:///var/storage/newsbody/2022/0330/19841942.html http://www.streetinsider.com/PRNewswire/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html Wed, 30 Mar 2022 02:19:00 -0400 ALZ ALZ http://www.streetinsider.com/PRNewswire/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html si-local-file:///var/storage/newsbody/2022/0330/19841942.html http://www.streetinsider.com/PRNewswire/Alzinova+improves+manufacturing+process+of+ALZ-101+to+meet+phase+2+requirements/19841942.html Wed, 30 Mar 2022 02:19:00 -0400 ALZ ALZ http://www.streetinsider.com/Press+Releases/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html si-local-file:///var/storage/newsbody/2022/0120/19483005.html http://www.streetinsider.com/Press+Releases/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html Thu, 20 Jan 2022 11:00:00 -0400 ALZ ALZ http://www.streetinsider.com/Press+Releases/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html si-local-file:///var/storage/newsbody/2022/0120/19483005.html http://www.streetinsider.com/Press+Releases/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html Thu, 20 Jan 2022 11:00:00 -0400 ALZ ALZ http://www.streetinsider.com/PRNewswire/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html si-local-file:///var/storage/newsbody/2022/0120/19483005.html http://www.streetinsider.com/PRNewswire/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html Thu, 20 Jan 2022 11:00:00 -0400 ALZ ALZ http://www.streetinsider.com/PRNewswire/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html si-local-file:///var/storage/newsbody/2022/0120/19483005.html http://www.streetinsider.com/PRNewswire/Alzinova+completes+humanisation+work+and+selects+lead+candidate+for+monoclonal+antibody+ALZ-201/19483005.html Thu, 20 Jan 2022 11:00:00 -0400 ALZ ALZ http://www.streetinsider.com/Press+Releases/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html si-local-file:///var/storage/newsbody/2021/1029/19128225.html http://www.streetinsider.com/Press+Releases/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html Fri, 29 Oct 2021 09:08:00 -0400 A.33568732 ALZ http://www.streetinsider.com/Press+Releases/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html si-local-file:///var/storage/newsbody/2021/1029/19128225.html http://www.streetinsider.com/Press+Releases/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html Fri, 29 Oct 2021 09:08:00 -0400 A.33568732 ALZ http://www.streetinsider.com/PRNewswire/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html si-local-file:///var/storage/newsbody/2021/1029/19128225.html http://www.streetinsider.com/PRNewswire/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html Fri, 29 Oct 2021 09:08:00 -0400 A.33568732 ALZ http://www.streetinsider.com/PRNewswire/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html si-local-file:///var/storage/newsbody/2021/1029/19128225.html http://www.streetinsider.com/PRNewswire/First+patient+recruited+into+Alzinova%27s+phase+1b+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+against+Alzheimer%27s+disease/19128225.html Fri, 29 Oct 2021 09:08:00 -0400 A.33568732 ALZ http://www.streetinsider.com/Press+Releases/Alzinova+receives+approval+to+start+the+first+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+in+patients+with+Alzheimer%27s+disease/19004565.html si-local-file:///var/storage/newsbody/2021/0930/19004565.html http://www.streetinsider.com/Press+Releases/Alzinova+receives+approval+to+start+the+first+clinical+study+with+the+oligomer-specific+ALZ-101+vaccine+in+patients+with+Alzheimer%27s+disease/19004565.html Thu, 30 Sep 2021 08:44:00 -0400 ALZ ALZ